Home/Ocean Biomedical/Suren Ajjarapu, CPA
SA

Suren Ajjarapu, CPA

Chief Financial Officer

Ocean Biomedical

Ocean Biomedical Pipeline

DrugIndicationPhase
OCEA-101 (CSPG4 mAb)Non-Small Cell Lung Cancer, MelanomaPreclinical
Fibrosis ProgramNASH / Liver FibrosisDiscovery/Preclinical
Malaria ProgramPlasmodium vivax MalariaPreclinical
B7-H3 ProgramSolid TumorsDiscovery